Ethical considerations are paramount in drug development. Epidemiologists ensure that clinical trials are conducted ethically, with informed consent from all participants. They also ensure that the risks are minimized and the potential benefits justify those risks. Institutional Review Boards (IRBs) play a critical role in overseeing the ethical aspects of the studies.